Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Data, Statistics and Legislation
  3. Prescription Drug Price Transparency
Topic Menu

Prescription Drug Price Transparency

  • Rx Transparency Home
  • Announcements
  • Data and Dashboards
  • Publications
  • For Reporting Entities

Related Sites

  • Health Economics Program
  • 340B Reporting
  • Accessible Prescription Drug Labels

Prescription Drug Price Transparency

  • Rx Transparency Home
  • Announcements
  • Data and Dashboards
  • Publications
  • For Reporting Entities

Related Sites

  • Health Economics Program
  • 340B Reporting
  • Accessible Prescription Drug Labels
Contact Info
Prescription Drug Price Transparency Program
651-201-4520
health.rx@state.mn.us

Contact Info

Prescription Drug Price Transparency Program
651-201-4520
health.rx@state.mn.us

Prescription Drug Price Transparency
Publications

2024 Report to the Minnesota Legislature (PDF)

This report is the third RxPT legislative report. It presents analysis of the information reported to MDH through June 2023, provides a summary and timeline for the implementation of new work, and assesses the Act's progress toward statutory goals. (Updated January 2025)

2023 Report to the Minnesota Legislature (PDF)

This report is an update to the first RxPT legislative report. It presents an overview of the Prescription Drug Price Transparency Act, analysis of data reported through November 2022, provides implementation updates, and identifies next steps for the program. (September 2023)

2022 Report to the Minnesota Legislature (PDF)

This report presents an overview of the Prescription Drug Price Transparency Act, analysis of data reported through June 2022, and a preliminary discussion of the effectiveness of the act. (Feb. 2023)

Tags
  • rx transparency
Last Updated: 03/12/2025

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube